Azeliragon-d9 (TTP488-d9) is the deuterium labeled Azeliragon (HY-50682). Azeliragon (TTP488) is an orally bioavailable inhibitor of the receptor for advanced glycation end products (RAGE) in development as a potential treatment to slow disease progression with mild Alzheimers disease (AD)[1]. Azeliragon also can cross the blood-brain barrier (BBB)[2].
Molekulargewicht:
541.17
Formel:
C32H29D9ClN3O2
Target-Kategorie:
Amyloid-beta,Isotope-Labeled Compounds
Anwendungsbeschreibung:
MCE Product type: Isotope-Labeled Compounds
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
